Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells by Reantragoon, Rangsima et al.
Article
The Rockefeller University Press $30.00
J. Exp. Med. 2013 Vol. 210 No. 11 2305-2320
www.jem.org/cgi/doi/10.1084/jem.20130958
2305
Mucosal-associated invariant T cells (MAIT cells) 
are innate-like T cells, comprising up to 10% of 
the peripheral blood T cells in humans, and are 
present in high frequency in the gastrointestinal 
mucosa and liver (Treiner et al., 2003; Martin 
et al., 2009; Dusseaux et al., 2011). MAIT cells are 
also present in mice, although their frequencies 
are extremely rare in laboratory strains of mice 
tested to date (Tilloy et al., 1999; Treiner et al., 
2003). MAIT cells may play a role in protective 
immunity and are implicated in several auto-
immune disorders (Croxford et al., 2006; Gold 
et al., 2010; Le Bourhis et al., 2010, 2011, 2013; 
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Mucosal-associated invariant T cells (MAIT cells) express a semi-invariant T cell receptor 
(TCR) -chain, TRAV1-2–TRAJ33, and are activated by vitamin B metabolites bound by the 
major histocompatibility complex (MHC)–related class I–like molecule, MR1. Understanding 
MAIT cell biology has been restrained by the lack of reagents to specifically identify and 
characterize these cells. Furthermore, the use of surrogate markers may misrepresent the 
MAIT cell population. We show that modified human MR1 tetramers loaded with the 
potent MAIT cell ligand, reduced 6-hydroxymethyl-8-d-ribityllumazine (rRL-6-CH2OH), 
specifically detect all human MAIT cells. Tetramer+ MAIT subsets were predominantly CD8+ 
or CD4CD8, although a small subset of CD4+ MAIT cells was also detected. Notably, most 
human CD8+ MAIT cells were CD8+CD8/lo, implying predominant expression of CD8 
homodimers. Tetramer-sorted MAIT cells displayed a TH1 cytokine phenotype upon antigen-
specific activation. Similarly, mouse MR1–rRL-6-CH2OH tetramers detected CD4+, 
CD4CD8 and CD8+ MAIT cells in V19 transgenic mice. Both human and mouse MAIT 
cells expressed a broad TCR- repertoire, and although the majority of human MAIT cells 
expressed TRAV1-2–TRAJ33, some expressed TRAJ12 or TRAJ20 genes in conjunction with 
TRAV1-2. Accordingly, MR1 tetramers allow precise phenotypic characterization of human 
and mouse MAIT cells and revealed unanticipated TCR heterogeneity in this population.
© 2013 Reantragoon et al. This article is distributed under the terms of an 
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first 
six months after the publication date (see http://www.rupress.org/terms). After 
six months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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with the use of this surrogate phenotype because of the po-
tential down-regulation of CD161 after MAIT cell activation 
(Leeansyah et al., 2013) as exemplified in two recent studies 
of MAIT cells in HIV-infected subjects (Cosgrove et al., 2013; 
Leeansyah et al., 2013). Here, the loss of CD161hiTRAV1-2+ 
cells was interpreted as a loss of MAIT cells associated with 
HIV infection (Cosgrove et al., 2013); however, it was dem-
onstrated that although many MAIT cells persisted, CD161 
down-regulation rendered them undetectable using the CD161hi 
TRAV1-2 surrogate phenotype (Leeansyah et al., 2013). More-
over, the current characterization of MAIT cells in mice is even 
more challenging as V19-specific mAbs are unavailable for 
mouse MAIT cells. Recently, we identified a series of MR1-
restricted ligands that originated from vitamin B, which in-
cludes the nonactivating folic acid metabolite, 6-formyl pterin 
(6-FP), and the highly potent riboflavin metabolite, reduced 
6-hydroxymethyl-8-d-ribityllumazine (rRL-6-CH2OH), thereby 
providing the opportunity to develop Ag-specific multivalent 
reagents to track MAIT cells ex vivo (Kjer-Nielsen et al., 2012). 
Here, we show that MR1 tetramers bound to the potent MAIT 
cell–activating ligand rRL-6-CH2OH specifically detect MAIT 
cells in humans and mice, revealing heterogeneity in the 
human MAIT cell Ag receptor repertoire and defining pheno-
typic characteristics of these cells.
RESULTS
MR1 tetramer generation
One potential hurdle in generating tetrameric reagents is that 
they generally require refolding and loading with a specific 
Ag such that the efficiency of this refolding/loading process 
can determine the broad applicability of the tetrameric re-
agent. Moreover, the associated stability of tetramers and po-
tential Ag register shifts, as frequently observed with MHC-II 
tetramers, can impact their reliability (Davis et al., 2011). MR1 
is distinct from other MHC-like Ag-presenting molecules, in 
that the Ag-binding cleft contains an aromatic cradle of resi-
dues that is ideally suited to bind small molecule metabolites 
(Kjer-Nielsen et al., 2012). Nevertheless, we have found the 
refolding efficiencies with the MR1 ligands to be very low 
(not depicted), creating a challenge to develop MR1-Ag tet-
ramers as universal and readily applicable reagents. The MR1-
binding cleft is mostly hydrophobic, but at the base of the 
cleft Lys43 forms a Schiff base with 6-FP (Fig. 1 A). Hence, 
we reasoned that the formation of a covalent bond with Lys43 
might be a critical driving force in efficient refolding with 
MR1-restricted ligands. To formally test this, we engineered 
human and mouse MR1 in which Lys43 was mutated to Ala 
(K43A). Both the mouse and human MR1-K43A molecules 
refolded in the absence of any added ligand (Fig. 1 B). This 
was surprising as MHC and CD1 Ag-presenting molecules 
are typically only stable in the presence of bound Ag. The re-
folded “empty” MR1-K43A mutants (termed MR1-empty) 
exhibited similar biophysical properties to that of refolded 
wild-type MR1–6-FP complexes (Fig. 1 B and not depicted) 
and reacted with the anti-MR1 mAb 26.5 similarly to that of 
wild-type MR1–6-FP (not depicted). An empty and stable 
Miyazaki et al., 2011; Chiba et al., 2012; Chua et al., 2012; 
Cosgrove et al., 2013; Gold and Lewinsohn, 2013; Leeansyah 
et al., 2013; Meierovics et al., 2013). MAIT cells, when activated 
via the antigen (Ag)-specific  TCR, rapidly secrete cyto-
kines, including IFN-, TNF, IL-17 in humans (Dusseaux et al., 
2011) and IFN-, IL-4, IL-5, and IL-10 in V19i transgenic 
(Tg) mice (Kawachi et al., 2006). Consistent with their innate- 
like properties, MAIT cells express a very restricted T cell 
repertoire. Namely, in humans, MAIT cells express an invariant 
TCR -chain, V7.2 (TRAV1-2), joined to J33 (TRAJ33), 
which is paired with a limited array of TCR -chains (pre-
dominantly TRBV6 or TRBV20; Tilloy et al., 1999). In mice, 
the MAIT TCR repertoire comprises the orthologous TCR 
-chain (V19J33) paired with V6 or V8 (TRBV19 or 
TRBV13). N-region additions are also found at the V-J 
junctions of MAIT TCRs, so the TCR -chain is not com-
pletely invariant even though these residues are located at the 
base of the CDR3 loops rather than at the sites of direct Ag 
recognition (Reantragoon et al., 2012; Patel et al., 2013). The 
MAIT TCR is restricted to the ubiquitously expressed MHC 
class I (MHC-I)–related molecule MR1 (Treiner et al., 2003), 
which is only found in mammals and exhibits a very high level 
of sequence conservation between mice and humans, thereby 
underscoring the evolutionary importance of the MAIT–MR1 
axis in immunity. Recently, we described a family of microbially 
derived vitamin B metabolites presented by MR1 that specif-
ically activate MAIT cells and provided the molecular basis 
for MAIT TCR recognition of vitamin B metabolites (Kjer-
Nielsen et al., 2012; Patel et al., 2013). These findings correlated 
with bacteria and yeast that stimulate MAIT cells possessing 
an intact riboflavin synthesis pathway, whereas this pathway is 
deficient in nonstimulatory microbes (Gold et al., 2010; 
Le Bourhis et al., 2010; Kjer-Nielsen et al., 2012). The definition 
of MR1-restricted ligands enables the function of MAIT cells 
to be probed in an Ag-dependent manner. However, a key to 
understanding MAIT cell physiology and pathology is the 
development of Ag-specific reagents, for example MR1-Ag 
tetramers, to characterize MAIT cells ex vivo. Tetramers of Ag- 
presenting molecules permit Ag-specific T cells to be isolated, 
quantified, tracked, and characterized from the milieu of 
T cells within the host (Altman et al., 1996; Davis et al., 2011). 
Indeed, the advent of tetramers and more elaborate multiva-
lent technology has been of huge benefit in the characteriza-
tion of MHC-I–, MHC-II–, and CD1d-restricted T cells and 
has also recently emerged for CD1b- and CD1c-restricted 
T cells (Benlagha et al., 2000; Matsuda et al., 2000; Kasmar 
et al., 2011; Ly et al., 2013).
Presently, human MAIT cells are phenotypically defined as 
CD3+, CD161hi, TRAV1-2+ T cells. There are clear limitations 
to this approach as their classification relies on reactivity with 
an anti–TRAV1-2 mAb, noting that TRAV1-2+ TCR usage is 
not limited to MAIT cells. For instance, public MHC-restricted 
T cells, as well as CD1b-restricted GEM T cells, also use this 
TRAV gene segment (Miles et al., 2005; Tynan et al., 2007; 
Van Rhijn et al., 2013), potentially leading to misleading clas-
sification of MAIT cells. Furthermore, there are risks associated 
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three different TCR -chains (TRBV6-1, TRBV6-4, and 
TRBV20; Fig. 2 A). Empty MR1-tetramers did not bind to 
the SKW.MAIT cells (Fig. 2 A, left). MR1-Ag tetramers spe-
cifically bound all three SKW.MAIT cells but did not bind to 
SKW.LC13 cells expressing the MHC-I–restricted antiviral 
TCR LC13 (Fig. 2 A, right; Kjer-Nielsen et al., 2003). These 
data demonstrate that MR1-Ag tetramers could efficiently 
bind MAIT TCRs using a range of distinct TCR -chains 
derived from human MAIT cells (Tilloy et al., 1999).
Detection of primary MAIT cell subsets
We next stained PBMCs from healthy donors with human 
MR1-Ag tetramers and compared the results with the estab-
lished MAIT cell–staining protocol using anti-CD3, CD161, 
CD4, and TRAV1-2 markers. In agreement with MR1-Ag 
tetramer staining of the MAIT TCR–transduced SKW3 cells, 
a discrete population of PBMCs stained with the MR1-Ag 
tetramer in comparison with the MR1-empty tetramer, high-
lighting the specificity of the MR1-Ag tetramers (Fig. 2 B). 
Consistent with previous studies (Martin et al., 2009; Dusseaux 
et al., 2011), MR1-Ag tetramer+ cells were predominantly 
CD4 and CD161hi (Fig. 2 C). There was a close correlation 
soluble MR1 suggested we could potentially load different 
MR1-restricted Ags of choice to generate MR1-Ag–specific 
reagents. Thus, we incubated the potent MAIT cell agonist 
rRL-6-CH2OH with MR1-empty, after which loading of 
MR1 with rRL-6-CH2OH was demonstrated by addition of 
soluble MAIT TCR and purification by gel-filtration chro-
matography of the ternary complex (Fig. 1, C and D). To fur-
ther demonstrate that MR1-K43A binds ligands in the same 
manner as wild-type MR1, the ternary structure of refolded 
MR1-K43A, loaded with the MAIT cell agonist RL-6- 
Me-7-OH and complexed to a MAIT TCR, was determined 
(Fig. 1 E and Table 1). This revealed virtually identical modes 
of MAIT TCR binding to RL-6-Me-7-OH bound to MR1-
K43A, when compared with the recently solved structure of 
the MAIT TCR–MR1–RL-6-Me-7-OH complex (Patel et al., 
2013). Thus, MR1-K43A and wild-type MR1 present ribo-
flavin metabolites to MAIT cells in a highly similar manner.
Tetrameric versions of human mutant K43A MR1-empty 
and MR1–rRL-6-CH2OH were formed by streptavidin cross- 
linking of biotin-labeled MR1, and these tetramers (MR1-Ag 
tetramers) were tested for their ability to stain the human 
T cell line SKW3 expressing MAIT TCRs (SKW.MAITs) with 
Figure 1. Refolding and subsequent loading of mutant 
Lys43→Ala MR1 (MR1-K43A) with rRL-6-CH2OH. (A) Struc-
ture of wild-type human MR1 (green) with 6-FP (blue) form-
ing a Schiff base with lysine 43 (K43; yellow). Van der Waal 
contacts (red) and hydrogen bonds (black) are shown  
(Kjer-Nielsen et al., 2012). (B) 15% SDS-PAGE of graded 
amounts of refolded and purified wild-type MR1 (MR1–6-FP; 
refolded with 6-FP), and empty MR1-K43A. Molecular mass 
markers are indicated in kilodaltons. This experiment was 
performed three times; shown is a representative experiment. 
(C) Gel filtration (S200 10/300 GL; GE Healthcare) purification 
of ternary complex: MR1-K43A (MR1) was loaded with rRL-6-
CH2OH and subsequently complexed with soluble MAIT TCR 
(TCR). Ternary complex (MR1 + TCR) elutes at an earlier  
retention time than MR1 and MAIT TCR alone. Absorption  
at 280 nm and volume (ml) are shown on the y and x axis,  
respectively. (D) 15% SDS-PAGE of the ternary complex of 
MR1-K43A (loaded with rRL-6-CH2OH) and soluble MAIT TCR 
(purified by gel filtration as shown in C). Shown are molecu-
lar mass markers (in kilodaltons) and MAIT TCR (TCR), MR1-
K43A (MR1), and ternary complex (MR1 + TCR) as indicated. 
(C and D) These experiments were performed twice; shown 
are representative experiments. (E) Overlay of ternary MR1-
K43A–RL-6-Me-7-OH–MAIT TCR complex, with wild-type 
MR1–RL-6-Me-7-OH–MAIT TCR complex (Patel et al., 2013), 
viewed down into the Ag-binding cleft. RL-6-Me-7-OH in 
MR1-K43A–RL-6-Me-7-OH–MAIT TCR complex, yellow; RL-6-
Me-7-OH in wild-type MR1–RL-6-Me-7-OH–MAIT TCR com-
plex, magenta; MR1 in MR1-K43A–RL-6-Me-7-OH–MAIT TCR 
complex, gray; MR1 in wild-type MR1–RL-6-Me-7-OH–MAIT 
TCR complex, cyan; oxygen, red; nitrogen, blue.
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transduction, thus playing a crucial role in the development of 
T cells expressing MHC-I–restricted TCRs. CD8 comprises 
two subunits, CD8 and CD8, encoded by two distinct genes, 
with CD8 existing in two isoforms, the  homodimer and 
the  heterodimer. The CD8 heterodimer is by far the 
most predominant isoform (>90%) on MHC-restricted CD8+ 
T cells, with the CD8 isoform being mostly restricted to 
gut intraepithelial lymphocytes (IELs; Das et al., 2000). Stain-
ing of PBMCs in six healthy donors using anti-CD8 mAbs 
demonstrated that the majority (>85%) of the tetramer+CD8+ 
subset was CD8+ or CD8/lo, implying predominant ex-
pression of CD8 homodimers, although some of these cells 
appear to coexpress CD8 heterodimers. In contrast, con-
ventional MHC-restricted T cells mostly express high levels of 
the CD8 heterodimer (Fig. 2 D, right). Accordingly, these 
data indicate that the human MR1 tetramer+ cells differ in 
their CD8 expression from conventional T cells and are more 
like intestinal T cells, which express CD8 homodimer.
Characterization of a noncanonical  
MAIT TCR repertoire in humans
The canonical human MAIT TCR utilizes the invariant TRAV1-
2–TRAJ33 -chain paired predominantly with TRBV6 and 
TRBV20 -chains (Tilloy et al., 1999). To investigate the 
MAIT TCR repertoire further in humans, the MR1-Ag tet-
ramer and a TRAV1-2–reactive mAb (3C10; BioLegend) 
were used to stain PBMCs from four and two donors, respec-
tively, after which single-cell sorted MR1-Ag tetramer+ or 
TRAV1-2+ cells were subjected to multiplex RT-PCR analysis 
(Wang et al., 2012) of their TCR genes, examining four T cell 
populations (CD3+CD4CD161hiMR1-Ag tetramer+; CD3+ 
CD4CD161hiTRAV1-2+; CD3+CD4CD161TRAV1-2+; 
and CD3+CD4+CD161hiTRAV1-2+; Fig. 3). Most sorted 
MR1-Ag tetramer+ and TRAV1-2+ cells expressed the canon-
ical TRAV1-2 gene segment joined to the TRAJ33 gene seg-
ment, thereby giving rise to the invariant TRAV1-2–TRAJ33 
-chain typically associated with MAIT TCRs (Tilloy et al., 
1999). However, the TRAV1-2 gene did not exclusively join 
with the TRAJ33 gene segment (Fig. 3 A). Between 8 and 
31% of sorted cells used TRAV1-2 joined with the TRAJ20 or 
TRAJ12 gene segments. This noncanonical TRAJ usage was 
observed using either MR1-Ag tetramers or mAb TRAV1-
2+/CD161hi markers to identify MAIT cells. TRAJ20+ MAIT 
cells have previously been reported (Gold et al., 2010, 2013), 
and although there have been other studies suggestive of rep-
ertoire diversity in MAIT cells (Ebato et al., 1994; Maru et al., 
2003; Hwang et al., 2006), these cannot be confirmed in the 
absence of definitive MAIT cell characterization. Our study 
demonstrates that in some individuals, a surprisingly high fre-
quency (up to 31%) of MR1-Ag tetramer+ or mAb TRAV1-
2+ cells can use alternative, non-TRAJ33 junctional genes. 
Although the sequences of TRAJ33, TRAJ20, and TRAJ12 
differ slightly, they are relatively conserved overall, and notably, all 
three gene segments contained the conserved Tyr95 residue 
within the CDR3 loop (Fig. 3 B), which was previously shown 
to be crucial for MAIT cell activation (Reantragoon et al., 2012; 
between the percentage of MR1-Ag tetramer+ cells and the 
percentage of TRAV1-2+CD161hi cells (Fig. 2 C). Of note, 
from six donors, 10–24% of the TRAV1-2+, CD4 cells 
did not express high levels of CD161 (CD161hi), but an 
equivalent CD161lo tetramer-positive population was absent, 
presumably reflecting TRAV1-2 usage by non-MAIT cells 
(Fig. 2 C, bottom left). In addition, the TRAV1-2 mAb com-
petes with MR1–rRL-6-CH2OH tetramer staining, indicat-
ing that the MR1-Ag tetramer was binding to TRAV1-2+ 
TCRs (not depicted).
As previously established for the current definition of 
MAIT cells within PBMCs, TRAV1-2+CD161hi T cells seg-
regated mostly into the CD8+ and double-negative (DN) 
subsets, whereas the CD4+TRAV1-2+CD161hi subset was minor 
by comparison in five out of six donors (2–11% of MR1-Ag 
tetramer+ cells; Fig. 2, C and D). In the sixth donor, we ob-
served low intensity of staining with MR1-Ag tetramer with 
a higher proportion (32%) of MR1-Ag tetramer+ cells that 
were CD4+ (not depicted). CD8 mediates adhesion and signal 
Table 1. Data collection and refinement statistics
Parameter MAIT–MR1-K43A–RL-6-Me-7-OH
Data collection
Temperature 100K
Space group C2
Cell dimensions
a, b, c (Å) 215.91, 69.36, 142.83
, ,  (°) 90, 104.30, 90
Resolution (Å) 75.01-2.40 (2.53-2.40)
Rpima 7.9 (36.8)
I/1 7.4 (2.1)
Completeness (%) 99.8 (99.9)
Total no. of observations 344,942 (50,778)
No. of unique observations 80,366 (11,654)
Multiplicity 4.3 (4.4)
Refinement statistics
Rfactor (%)b 17.9
Rfree (%)c 22.7
No. of atoms
Protein 12,417
Ligand 46
Water 334
Ramachandran plot (%)
Most favored 91.0
Allowed region 9.0
B factors (Å2)
Protein 35.4
Ligand 28.7
rmsd bonds (Å) 0.010
rmsd angles (°) 1.11
Values in parentheses refer to the highest resolution bin.
aRpim = hkl [1/(N  1)]1/2 i|Ihkl, i  <Ihkl>|/hkl <Ihkl>.
bRfactor = (||Fo|  |Fc||)/(|Fo|) for all data except as indicated in footnote c.
c5% of data was used for the Rfree calculation.
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P < 0.0001 for TRAJ20, Fisher’s exact test), suggesting pref-
erential pairing of these TCRs may be associated with non-
canonical MAIT cell development (Fig. 3 C). These findings 
collectively reveal unexpected heterogeneity in the MAIT 
TCR repertoire.
Identical Ag dependence of MAIT cells  
expressing noncanonical TCRs
To formally investigate whether the noncanonical, cell surface 
phenotype–defined MAIT TCRs were MR1 restricted and Ag 
specific, we transduced genes encoding TRAV1-2–TRAJ20 
and TRAV1-2–TRAJ12 TCRs into SKW3 cells, along with 
their cognate TRBV genes. These SKW.MAIT TCR trans-
ductants bound to MR1-Ag tetramers but not to MR1-empty 
tetramers (Fig. 4 A). The single TRAV1-2–TRAJ4 TRBV6-4 
TCR was also included in this panel of transductants, but, as 
anticipated by the lack of Tyr95, it did not stain with MR1-
Ag tetramers (Fig. 4 A). Furthermore, the TRAV1-2–TRAJ4+ 
SKW transductant was not activated by Salmonella typhimurium 
Patel et al., 2013; Young and Gapin, 2013). A single TRAV1-
2+TRAJ4+TRBV6-4+ clone was also identified within the 
TRAV1-2+CD161hi fraction, but this lacked Tyr95, making 
it less likely to be a MAIT cell.
In the MAIT cell population where TRAV1-2 was joined 
with TRAJ33, the paired TCR- segments were dominated 
by TRBV6-4 and TRBV20 genes, as previously reported 
(Tilloy et al., 1999), but TRAV1-2–TRAJ33 -chains also 
paired with TRBV28, TRBV25, TRBV24, TRBV19, TRBV15, 
TRBV11-2, TRBV6-5, TRBV6-1, TRBV4-3, and TRBV4-2 
(Fig. 3, A and C). This is consistent with mutagenesis and 
structural studies of the human MAIT TCR showing that the 
residues critical to MR1-mediated recognition were largely 
confined to the MAIT TCR -chain and CDR3 loop of 
the MAIT TCR -chain (Reantragoon et al., 2012; Patel et al., 
2013; Young and Gapin, 2013). Interestingly, although sam-
pled from a more limited number of cells, the TRBV usage 
in the noncanonical TRAJ20+ and TRAJ12+ MAIT cells was 
dominated by TRBV6-4 genes (P < 0.0001 for TRAJ12 and 
Figure 2. Ag-specific identification of 
human MAIT cells. (A) Direct immunofluores-
cent staining of SKW3 cells expressing MAIT 
TCRs: TRAV1-2–TRAJ33 with TRBV6-1, TRBV6-4,  
or TRBV20, with empty (left) or rRL-6-CH2OH–
loaded (right) human MR1 tetramer. Controls 
include nontransduced SKW3 (Parental SKW) 
and SKW3-transduced with an irrelevant TCR 
(LC13 TCR). (B) Human PBMCs were stained 
with CD3- and CD161-reactive mAbs and  
human MR1 tetramer. Shown are dot plots of 
CD3+ cells stained with empty (left) or rRL-6- 
CH2OH–loaded (right) human MR1 tetramer. 
Percentages of cells within boxed regions are 
indicated. Tetramer and CD161 staining are 
shown on the y and x axis, respectively. (C) Stain-
ing of human PBMCs comparing percentages 
of CD3+CD4 (left) and CD3+CD4+ (right) T cells 
detected by human MR1-Ag tetramer or 
TRAV1-2 mAb. Percentages of cells within 
(black) boxed regions are indicated. Also  
indicated is the percentage (gray) of 
CD3+CD4TRAV1-2+CD161lo cells within the 
gray box (bottom left plot). Tetramer or TRAV1-
2 and CD161 staining are shown on the y and x 
axis, respectively. Experiments in A–C were 
performed three times with similar results; 
shown are representative experiments. (D) Co-
receptor expression on CD161+tetramer+ MAIT 
cells. CD3+CD161+tetramer+ cells were stained 
for cell surface expression of CD4, CD8, and 
CD8. CD8 (CD8+CD8) and CD8 
(CD8+CD8+) expression on CD8+ MAIT cells 
was subsequently compared with expression on 
conventional CD8+ T cells (n = 6; shown is a 
representative staining experiment).
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of these cells (Fig. 4 B). Thus, noncanonical MAIT TCRs 
share ligand specificity and functional properties of canonical 
MAIT cells expressing TRAV1-2–TRAJ33.
MAIT cells in the intestinal mucosa
As MAIT cells are enriched at mucosal sites, we determined 
whether TRAV1-2+ T cells could be detected in tissue sec-
tions from intestinal mucosa and whether these cells expressed 
the canonical MAIT TCR -chain sequences. Healthy human 
jejunal tissue was collected into cold PBS, after a Whipple’s 
procedure, and then fixed in cold 4% formaldehyde. Fixa-
tion buffer was washed out with PBS, and cryosections were 
processed for immunohistochemistry using the TRAV1-2–
specific mAb D5 (Kjer-Nielsen et al., 2012). TRAV1-2+ T cells 
were observed in the lamina propria, predominantly at the 
bases of the villi (Fig. 5 A, top). Occasionally, cells were ob-
served at the villus tip (Fig. 5 A, bottom), and there were rare 
IELs (Fig. 5 A, top, arrow). For detection of MAIT cells by flow 
cytometry, single-cell suspensions were prepared from jejunum 
tissue and were stained for CD3, CD4, CD161, and either MR1-
Ag tetramer or anti–TRAV1-2 mAb (D5), or empty MR1 
tetramer or isotype control mAb (Fig. 5 B). The proportion of 
MR1-Ag tetramer+CD161hi cells and TRAV1-2+CD161hi 
was similar (59.9–61.9% of CD3+CD4 lymphocytes, respec-
tively), revealing a significant enrichment of MAIT cells in 
the jejunal mucosa. Moreover, the majority of the TRAV1-2+ 
cells expressed TRAJ33 (Fig. 5 C) and paired with one or 
other of the TRBV6-4, TRBV20, TRBV19, and TRBV3-1 
TCR -chains (not depicted). Accordingly, MR1-Ag tetramer+ 
MAIT cells are highly enriched in healthy jejunal tissue and 
express a TCR repertoire largely typical of blood MAIT cells.
Functional activity of MR1-tetramer–reactive MAIT cells
To determine whether the MR1-Ag tetramers identified all 
detectable human MAIT cells, we performed depletion of 
MR1-tetramer+ cells by flow sorting and then tested the func-
tional activity of the remaining T cells. Depletion of cells with 
MR1-Ag tetramers removed T cell reactivity to both syn-
thetic rRL-6-CH2OH and S. typhimurium supernatant, de-
spite the presence of residual T cells expressing the TRAV1-2 
TCR (Fig. 6, A and B). Both depleted and nondepleted 
CD161+ T cells produced IFN- in response to anti-CD3 
and CD28 and PMA/ionomycin stimulation, demonstrat-
ing that CD161+ cells were capable of non-TCR–mediated 
activation (Fig. 6 B).
We next examined the cytokine profile of MR1-Ag 
tetramer+ cells activated by S. typhimurium supernatant or syn-
thetic rRL-6-CH2OH Ag using a cytometric bead array (CBA) 
assay. Human MR1-Ag tetramer+ CD3+ cells were purified 
by flow cytometric sorting and stimulated in the presence of 
different activation agents for 60 h in culture. Conventional 
(MR1-Ag tetramer, CD161) T cells produced IFN-, TNF, 
and IL-2 upon incubation with anti-CD3/anti-CD28 beads 
and by PMA/ionomycin; however, as expected, they were 
not significantly activated by synthetic rRL-6-CH2OH Ag or 
S. typhimurium supernatant in the presence of C1R-MR1 APCs 
(Fig. 6 C). In contrast, CD161hi MR1-Ag tetramer+ T cells 
infection, S. typhimurium supernatant, or synthetic rRL-6-
CH2OH Ag (Fig. 4 B) but was activated upon stimulation 
with CD3/CD28 mAbs (not depicted). Thus, this TCR did 
not appear to represent a MAIT TCR but served as a valuable 
negative control for the other noncanonical MAIT TCRs. 
However, the remaining SKW.MAIT transductants were spe-
cifically activated by S. typhimurium–infected C1R cells and 
by C1R cells to which MAIT-activating ligands, either fur-
nished from bacterial supernatant or as synthetic rRL-6-
CH2OH, had been added (Fig. 4 B; Kjer-Nielsen et al., 2012). 
Importantly, the activation of the SKW transductants express-
ing these noncanonical MAIT TCRs was blocked by coincu-
bation with an anti-MR1 mAb, but not an isotype-matched 
HLA-ABC–reactive mAb, confirming the MR1 restriction 
Figure 3. Characterization of MR1-Ag tetramer-reactive MAIT 
cells. (A) Bar graphs showing TRAJ usage of CD3+CD4CD161hitetramer+ 
cells (all of which expressed TRAV1-2; left, donors 1–4) or CD3+CD4 
CD161hiTRAV1-2+ cells (stained with the TRAV1-2–specific mAb 3C10; 
right, donors 5 and 6). Bars represent percentage of total sequences (n = 
32 [donor 1], 13 [donor 2], 43 [donor 3], 35 [donor 4], 37 [donor 5], and 
35 [donor 6]) obtained from PCR amplification. (B) Alignment of CDR3 
regions of TRAV1-2 TCR -chains containing TRAJ33, TRAJ12, and TRAJ20 
segments from CD161+tetramer+ cells. The conserved Tyr95 residue is 
highlighted in bold and underlined. (C) Pie charts comparing TRBV usage 
of MAIT cells with TRAV1-2 -chains containing either TRAJ33 (left), 
TRAJ20 (top right), or TRAJ12 segments (bottom right; n, total number of 
paired sequences pooled from donors 1–6, = 154 [TRAJ33], 17 [TRAJ20], 
and 25 [TRAJ12]).
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the Tg MAIT TCR -chains pair with endogenous TCR 
-chains (predominantly V6 and V8), thus enriching the 
number of MAIT cells (Okamoto et al., 2005; Croxford et al., 
2006; Kawachi et al., 2006; Martin et al., 2009; Le Bourhis et al., 
2010; Chua et al., 2012). To confirm the shared ligand specific-
ity of human and mouse MAIT cells and to characterize the 
phenotype of mouse Tg MAIT cells, mouse MR1-Ag tetramers 
were used to stain splenic T cells from V19iTg-C/MR1+/+ 
mice as well as control V19iTg-C/MR1/, C57BL/ 
6-MR1/ (Fig.7, A–C), and C57BL/6 mice (not depicted). 
Empty MR1 tetramers did not stain a significant proportion of 
CD3+ cells from the spleens of any of these mice (Fig. 7, A–C, 
top), whereas the mouse MR1-Ag tetramers identified tetra-
mer+ T cells in the CD4+, DN, and CD8+ T cell populations 
of V19iTg-C/MR1+/+ mice (Fig. 7, A, bottom).
In contrast to human MAIT cells in which only a small 
proportion of MAIT cells expressed CD4 (mean 6%; Fig. 2 D), 
>40% of MR1-Ag tetramer+ cells from a V19iTg-C/ 
MR1+/+ mouse were CD4+, with the remainder containing 
produced IFN-, TNF, and IL-2 upon incubation with syn-
thetic rRL-6-CH2OH Ag or S. typhimurium supernatant in 
the presence of C1R.MR1 APCs. Surprisingly, activation of 
MR1-Ag tetramer+ cells by MAIT ligands did not induce 
production of IL-17, in contrast with an earlier study showing 
that human blood MAIT cells possess a TH17-like functional 
phenotype (Dusseaux et al., 2011). This may reflect differ-
ences in the stimulation conditions and/or donor differences 
between the two studies. Collectively, these data indicate that 
the MR1-Ag tetramers recognize all MAIT cells and can be 
used for their functional characterization without tetramer-
mediated preactivation through the MAIT TCR.
Identification of mouse MAIT cells  
with mouse MR1-Ag tetramers
MAIT cells are extremely rare in standard laboratory strains of 
mice compared with humans (Tilloy et al., 1999; Treiner et al., 
2003). Hence, most studies of mouse MAIT cells have used 
Tg lines expressing V19i on a C/ background such that 
Figure 4. T cells expressing TRAV1-2–
TRAJ12 and TRAV1-2–TRAJ20 -chains 
reconstitute features of canonical TRAV1-2–
TRAJ33 MAIT cells. (A) Direct immunofluor-
escent staining of SKW3 cells expressing 
noncanonical MAIT TCRs: TRAV1-2–TRAJ12 with 
TRBV20 or TRBV6-4 and TRAV1-2–TRAJ20 with 
TRBV6-4, with empty (left) or human MR1-Ag 
tetramer (rRL-6-CH2OH loaded; right). Controls 
include a canonical MAIT TCR comprising TRAV1-
2–TRAJ33 and TRBV20 - and -chains and a 
non-MAIT TCR comprising TRAV1-2–TRAJ4 and 
TRBV6-4 - and -chains. This experiment was 
performed twice with similar results. (B) SKW3 
cells expressing noncanonical MAIT TCRs using 
TRAV1-2 joined with different TRAJs (M33.20, 
TRAV1-2–TRAJ33 plus TRBV20; M12.20, TRAV1-
2–TRAJ12 plus TRBV20; M12.64, TRAV1-2–TRAJ12 
plus TRBV6-4; M20.64, TRAV1-2–TRAJ20 plus 
TRBV6-4; and control non-MAIT TCR M4.64, 
TRAV1-2–TRAJ4 plus TRBV6-4) were activated by 
either infection with S. typhimurium (top left) or 
by addition of S. typhimurium supernatant (s/n; 
top right), rRL-6-CH2OH (bottom left), or rRL-6-
CH2OH in the absence or presence of the anti-
MR1 mAb (26.5) or an isotype control mAb 
(W6/32; bottom right). CD69 mean fluorescence 
intensity (MFI) is shown on the y axis. The tetra-
mer-staining experiment was performed twice; 
the S. typhimurium infection, addition of  
S. typhimurium supernatant, and addition of  
rRL-6-CH2-OH experiments were performed once, 
three times, and three times, respectively, with 
similar results. Error bars show SEM of triplicates. 
Representative results are shown.
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However, the proportion of tetramer-reactive cells, both as a 
percentage and as absolute numbers, was significantly less in 
splenocytes from V19iTg-C/MR1/ mice when com-
pared with V19iTg-C/MR1+/+ mice (Fig. 7, A, B, and D). 
This result is similar to what has been found for NKT cells, 
where CD1d–-GalCer tetramers stained a proportion of 
T cells from CD1d/ mice (Wei et al., 2006). Importantly, 
no clear population of splenocytes from both wild-type and 
C57BL/6-MR1/ mice was detected with MR1-Ag tetra-
mer when compared with staining by control empty MR1 
tetramer (Fig. 7, C and D; and not depicted). Because the 
numbers of MAIT cells in wild-type C57BL/6 mice are ex-
tremely low when compared with humans (Tilloy et al., 1999; 
Treiner et al., 2003), this observation is consistent with the 
notion that the presence of both V6+V8+ and V6V8 
MR1-Ag tetramer+ cells from V19iTg-C/ mice is not 
caused by nonspecific staining by MR1-Ag tetramers. Accord-
ingly, mouse MR1-Ag tetramers specifically detect V19i+  
T cells in the Tg mouse.
Functional activity of both V19iTg+ V6/V8 and  
V6/V8+ MR1-Ag tetramer–reactive mouse MAIT cells
There is currently no equivalent V19-specific mAb for the 
detection of MAIT cells in mice, such as the TRAV1-2–specific 
mAbs available for human MAIT cells. To verify that both 
V6+/V8+ and V6/V8 MR1-Ag tetramer+ T cells 
from V19iTg mice were capable of stimulation by rRL-6- 
CH2OH in an MR1-restricted manner, we tested V6+/V8+ 
more DN than CD8+ cells (ratio 3–4:1; Fig. 7, A, bottom). 
Thus the phenotype of splenic mouse MR1-Ag tetramer+ 
cells created in the Tg model differs from the most frequent 
phenotype of natural human MAIT cells in blood. Interest-
ingly, we found that MR1-Ag tetramer+, CD4+ splenocytes 
were present in greater numbers in V19iTg-C/MR1+/+ 
mice when compared with V19iTg-C/MR1/ mice 
(Fig. 7, A, B, and D). In contrast, Kawachi et al. (2006) did not 
find significantly greater numbers of CD4+ splenocytes in 
V19iTg-C/MR1+/+ in comparison with V19iTg-C/ 
MR1/ mice. Notably, about two thirds of mouse MR1-Ag 
tetramer+ cells expressed the predominantly used V6 or V8 
genes, and about one third of the MR1-Ag tetramer+ cells 
were V6 and V8 (Fig. 7, A, bottom). It was not surprising 
that the T cells not expressing the preferentially used V6 and 
V8.1/8.2 segments in the V19iTg-C/MR1+/+ mice were 
reactive to MR1-Ag tetramer as other V segments can be 
used (Tilloy et al., 1999; Kawachi et al., 2006). Thus, it appears 
that in the same way that there is predominant but nonexclu-
sive TRBV6 and TRBV20 chain selection by human MAIT 
TCRs, mouse MAIT TCRs can also use other -chains in ad-
dition to the predominantly used V6 and V8. We confirmed 
this finding by RT-PCR analysis of TCR genes from BW5147 
hybridomas generated from fusion with sorted MR1-Ag 
tetramer+ V6V8 and V6+V8+ T cells (Fig. 8 A and 
not depicted). Interestingly, tetramer-reactive cells were not 
completely absent from V19iTg-C/MR1/ mice lack-
ing the MR1 restriction element (Fig. 7, B [bottom] and D). 
Figure 5. In situ localization and TCR repertoire 
analysis of jejunal MAIT cells. (A) Immunohistochem-
ical staining of MAIT cells in the lamina propria in a 
human jejunal tissue section. Brown indicates TRAV1-2 
(D5 mAb) staining detected with peroxidase-conjugated 
secondary antibody. The red arrow shows an example of 
a TRAV1-2+ intraepithelial MAIT cell stained with the D5 
mAb. (B) Flow analysis of human IELs prepared from 
jejunal sections with mAbs against CD3, CD4, and 
CD161 and either human MR1-Ag tetramer (rRL-6-
CH2OH; top left) or empty MR1-tetramer (top right) or 
TRAV1-2–reactive mAb (V7.2; bottom left) or isotype 
control (bottom right). Tetramer or TRAV1-2 and CD161 
staining are shown on the y and x axis, respectively. 
This staining experiment was performed three times 
with similar results. (C) Pie chart showing TRAJ usage of 
MAIT IELs (CD161hiTRAV1-2+). Proportions are calcu-
lated from a total of 113 sequences.
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cells was compared with that of control MR1-Ag tetramer 
T cells using a CBA assay. MR1-Ag tetramer–positive cells, 
when stimulated by rRL-6-CH2OH in the presence of 
M12.C3.MR1 Ag-presenting cells, produced both IFN- and 
TNF, whether or not they were V6+/V8+ or V6/V8 
(Fig. 8, B and C). In contrast, MR1-Ag tetramer–negative cells 
were not stimulated by this Ag, although they could be stimu-
lated by anti-CD3/CD28 or PMA/ionomycin (Fig. 8, B and 
C). Collectively, the mouse MR1-Ag tetramers offer a highly 
specific tool for tracking MAIT cells and verify the shared 
ligand specificity of human and mouse MAIT cells.
DISCUSSION
The advent of both classical and nonclassical MHC tetramer 
technology has revolutionized investigations into T cell– 
mediated immunity (Davis et al., 2011). Within the MHC axis, 
specific MHC-laden peptides need to be bound in a defined 
register to enable epitope-specific tracking of T cells. For CD1d- 
restricted NKT cells, which are usually characterized by invari-
ant TRAV10-TRAJ18 TCR usage (which defines type I NKT 
cells), a universal CD1d-restricted Ag, -galactosylceramide, is 
routinely used to track virtually the entire population of these 
cells (Benlagha et al., 2000; Matsuda et al., 2000). Moreover, 
tetrameric versions of less potent CD1d-restricted Ags can 
and V6/V8 BW5147-MAIT cell hybridomas (derived 
from the fusion of MR1-Ag tetramer sorted splenocytes 
from a V19iTg-C/MR1+ mouse) for their capacity to 
be activated by rRL-6-CH2OH (Fig. 8 A). Both V6+/V8+ 
and V6/V8 BW5147-MAIT hybridomas (which were 
MR1-Ag tetramer+) were stimulated by rRL-6-CH2OH to 
produce IL-2, and this activation was blocked by the MR1- 
specific mAb 26.5 but not the isotype control mAb W6/32 
(Fig. 8 A, left). In contrast, a control BW5147 hybridoma, which 
did not stain with MR1-Ag tetramer, was not activated by 
rRL-6-CH2OH. (Fig. 8 A, left). As expected, RT-PCR analy-
sis of RNA from the BW5147-MAIT hybridomas confirmed 
the presence of non-V6/V8 and V6/V8 TCR chains in 
V6/V8 and V6+/V8+ hybridomas, respectively (not 
depicted). All BW5147 hybridomas were activated upon 
anti-CD3/CD28 mAb stimulation (Fig. 8 A, right). To fur-
ther verify that MR1-Ag tetramer–reactive mouse splenocytes 
recognize rRL-6-CH2OH, CD3+MR1-Ag tetramer+V6+/
V8+, CD3+MR1-Ag tetramer+V6/V8, or CD3+MR1-
Ag tetramer splenocytes from V19iTg+ mice were purified 
by flow cytometric sorting. Sorted cells were then coincubated 
with M12.C3.MR1 cells (expressing high levels of transduced 
mouse MR1) in the presence or absence of rRL-6-CH2OH, 
and production of IFN- and TNF by MR1-Ag tetramer+ 
Figure 6. MR1-Ag tetramer detects all 
MAIT cells. (A and B) Human PBMCs were 
depleted of MAIT cells by staining with rRL-6- 
CH2OH–loaded human MR1 tetramer and 
subsequent sorting by flow cytometry. Two-
dimensional dot plots show analytical stain-
ing of a fraction of cells after sorting with 
TRAV1-2 staining (y axis; using the anti–
TRAV1-2–specific mAb D5) versus CD161 
staining (x axis) after tetramer depletion 
(left) or with control undepleted cells (right). 
Cells subsequently used in the experiment 
depicted in B were not subjected to prior 
treatment with mAbs. Undepleted and tetra-
mer-depleted PBMCs were treated with rRL-6- 
CH2OH or S. typhimurium supernatant (S/N) 
or had no treatment (Nil) in the presence of 
C1R.MR1 cells or were treated with anti-
CD3/anti-CD28 beads or PMA/ionomycin 
(Iono). Bar graphs shown are gated on 
CD3+CD4CD161+ T cells. Bars represent 
percentage of IFN-–producing cells  
(% IFN+ cells). This MAIT tetramer depletion 
experiment was performed three times; a 
representative experiment is shown. The 
experiment was performed in triplicate, and 
shown are means. (C) Human PBMCs were 
stained with CD3- and CD161-reactive mAbs, 
and rRL-6-CH2OH–loaded MR1 tetramer and 
CD3+CD161hi MR1-Ag tetramer+ cells were 
then sorted before either no treatment (T cells only) or treatment with anti-CD3/anti-CD28 beads (CD3/CD28) or PMA/ionomycin or were coincubated 
with C1R.MR1 cells in the absence of treatment (Nil) or with the addition of rRL-6-CH2OH or S. typhimurium supernatant. Production (pg/ml) of IFN-,  
TNF, and IL-2 by MAIT cells or control CD3+CD161 MR1-Ag tetramer T cells (T conv) was measured using a CBA assay. The mean of duplicate sam-
ples is shown, with error bars indicating SEM.
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the lack of a V19-specific mAb. Our limited understanding 
of MAIT cell function is principally attributable to lack of 
knowledge of the nature of the MR1-restricted MAIT cell 
Ag, and consequently not having Ag-specific reagents to track 
and characterize MAIT cells ex vivo. The recent description 
of riboflavin metabolites as MAIT cell Ags (Kjer-Nielsen et al., 
2012) has afforded the opportunity to develop an MR1-Ag 
tetrameric reagent that can essentially monitor the entire pop-
ulation of MAIT cells.
As the efficiency of MR1 refolding with the vitamin B 
metabolites was found to be very low, thereby potentially lim-
iting widespread use of a tetrameric reagent, we engineered 
MR1 so that it could be refolded in the absence of an added 
ligand. This empty MR1 exhibited essentially identical chro-
matographic and structural properties when compared with 
wild-type MR1, yet possessed the potential of being loaded 
with any putative MR1-restricted Ag of choice. To test the 
ability of this reagent to detect MAIT cells, we generated MR1 
help delineate how variations within the type I NKT cell 
TCR -chain repertoire can impact Ag recognition (Pellicci 
et al., 2009; Matulis et al., 2010). More recent studies have also 
demonstrated the potential for use of CD1b and CD1c tetra-
mers loaded with microbial Ags to detect CD1b- and CD1c-
restricted T cells, respectively (Kasmar et al., 2011; Ly et al., 
2013). In this study, we have generated MR1-Ag–loaded tet-
ramers and demonstrate the power of tetramer technology for 
the study of MAIT cells.
Despite the abundance of MAIT cells in humans (up to 10% 
of PBMC T cells), they have largely remained unexplored, 
and clinical practice is essentially oblivious to the presence 
and therapeutic use of MAIT cells. Furthermore, the utility 
of the surrogate TRAV1-2+, CD3+, CD161hi phenotype for 
MAIT cells has recently been called into question with a 
study showing that CD161 can be down-regulated on MAIT 
cells in HIV patients (Leeansyah et al., 2013). In mice, the 
problem of detection of MAIT cells is further confounded by 
Figure 7. Detection of mouse MAIT cells in V19iMR1+/+ Tg mice. (A–C) Staining of splenic pan T cells from V19iTg-C/MR1+/+ (A), 
V19iTg-C/MR1/ (B), and C57BL/6-MR1/ (C) mice with empty (top) or rRL-6-CH2OH–loaded (bottom) mouse MR1 tetramer in conjunction 
with mAbs reactive to V6, V8.1, and V8.2. Representative dot plots from one of three experiments show staining of CD4+ (left), CD4CD8 DN 
(middle), or CD8+ (right) cell populations. Tetramer and V6, V8.1, V8.2 staining is shown on the y and x axis, respectively. (D) Composite data 
from three separate experiments showing percentages (top row) and absolute numbers (bottom row) of splenocytes from V19iTg-C/MR1+/+ 
(TgMR1+/+), V19iTg-C/MR1/ (TgMR1/), or C57BL/6-MR1/ (B6-MR1/) mice stained with empty or rRL-6-CH2OH–loaded mouse MR1 
tetramer. Shown are staining of CD4+ (left), CD4CD8 DN (middle), or CD8+ (right) splenocytes that were either MR1-Ag+ and V6/V8.1/V8.2+ 
(6/8+) or V6/V8.1/V8.2 (6/8).
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between mouse (as defined by the V19iTg mouse) and human 
MAIT cells, with the CD4+ subset representing 40–50% in 
the mouse, in contrast with the presence of 2–11% of CD4+ 
MAIT cells in humans, thereby suggesting differing corecep-
tor requirements between these species. Furthermore, it was 
notable that in humans the CD8+ MAIT cell subset was mostly 
CD8+ CD8/lo, suggesting they predominantly express the 
CD8 coreceptor, a CD8 coreceptor form which is also 
found on IELs located within the gut and other epithelial 
surfaces, in parallel with the predominant location of MAIT 
cells. The presence of low levels of CD8 on CD8-high 
tetramers loaded with the potent rRL-6-CH2OH Ag. We 
demonstrate that MR1-Ag tetramers specifically detect human 
and mouse MAIT cells, thereby obviating the need for rely-
ing on the restricted TRAV1-2+CD161+CD3+ cell surface 
phenotype that is currently used to study human MAIT cells 
(Martin et al., 2009). Moreover, in the absence of a V19-
reactive mAb, the mouse MR1-Ag tetramers represent the 
first reagent that can be used to reliably track MAIT cells 
from the V19iTg mouse. Comparison of staining of human 
and mouse lymphocytes with MR1-Ag tetramers revealed that 
there was a difference in the coreceptor-dependent subsets 
Figure 8. Characterization of MR1-Ag 
tetramer–reactive mouse MAIT cells.  
(A) Activation of both V6/V8 and V6/
V8+ BW5147-MAIT hybridomas by rRL-6-
CH2OH. BW5147-MAIT hybridomas, either 
nonreactive with rRL-6-CH2OH–loaded MR1 
tetramer (Tet; Clone 5: Cl.5) or either MR1-
Ag tetramer+V6/V8 (Tet+6/8; Cl.2,3,4)  
or MR1-Ag tetramer+V6/V8+ (Tet+6/8+; 
Cl.1,18,20) were then (left) coincubated with 
M12.C3.MR1 cells in the absence (Nil) or pres-
ence of 15.2 µM rRL-6-CH2OH or presence of 
15.2 µM rRL-6-CH2OH with prior addition of 
either the MR1-reactive mAb 26.5 (+anti-
MR1) or an isotype control mAb, W6/32  
(+isotype). Alternatively (right), BW5147-MAIT 
hybridomas were incubated alone (Nil) or in 
the presence of CD3- and CD28-reactive 
mAbs. IL-2 release by BW5147-MAIT hybrid-
omas was measured by the conversion of  
o-phenylenediamine dihydrochloride by 
horseradish peroxidase in an indirect ELISA 
assay, and absorption at 492 nm is shown on 
the y axis. Results are shown as mean and 
SEM of triplicates. This experiment was per-
formed three times; shown is a representative 
experiment. (B and C) Activation of both 
V19iTg+ V6/V8 and V6/V8+ MAIT cells 
by rRL-6-CH2OH. Mouse splenocytes from 
three separate V19iTg-C/MR1+ litter-
mates were stained with CD3- and V6/V8-
reactive mAbs and rRL-6-CH2OH–loaded MR1 
tetramer. Sorted CD3+MR1-Ag tetramer 
(Tet), CD3+MR1-Ag tetramer+V6/V8 
(Tet+6/8), or CD3+MR1-Ag tetramer+V6/
V8+ (Tet+6/8+) cells were then coincubated 
with M12.C3.MR1 cells in the absence () or 
presence (+) of 15.2 µM rRL-6-CH2OH. Sorted 
T cells were also treated with either CD3- and 
CD28-reactive mAbs (CD3/CD28) or PMA and 
ionomycin (PMA/iono) or left untreated (Nil). 
Production (pg/ml) of IFN- (B) and TNF (C) by 
MAIT cells or control MR1-Ag tetramer– 
negative T cells was measured using a CBA 
assay after 24 h. These data are representative of two independent experiments. In this experiment, MAIT cells and T cells were separately sorted from 
three V19iTg-C/MR1+ littermates (mouse 1, MR1+/+; mouse 2, MR1+/; mouse 3, MR1+/), with each symbol representing an individual data point. 
Depending on numbers of available sorted cells, one to three in vitro replicates per parameter were tested. A similar result was obtained when this experi-
ment was repeated with MAIT and T cells separately sorted from two V19iTg-C/MR1+ littermates.
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it was interesting to note that they showed a bias in TRBV 
usage, with the vast majority expressing TRBV6-4, suggest-
ing preferential pairing of these TCR -chains with the non-
canonical TCR -chains. This alternate use of the TRAJ20/ 
TRAJ12 and TRAJ33 gene segments seem to be underpinned 
by a conserved Tyr95 residue within the J region of the 
CDR3 loop, whereupon this residue was shown to be a 
key requirement for MAIT TCR recognition (Reantragoon 
et al., 2012).
Despite the extensive heterogeneity of both the human 
and mouse MAIT cell populations, extending toward varied 
coreceptor usage, TCR -chain TRAJ usage (for human 
MAIT cells), and TCR -chain usage, the MR1-Ag tetramer 
effectively stains the majority of the human and V19iTg 
mouse MAIT cell population ex vivo. Moreover, coupled 
with the TRAV1-2 mAb, MR1-Ag tetramers can be used to 
verify MAIT cells in tissue sections. We demonstrate that 
human as well as V19iTg mouse MAIT cells, when activated 
by the potent rRL-6-CH2OH Ag, secrete a narrow range of 
TH1-biasing cytokines, which is in stark contrast to the TH1 
and TH2 range of cytokines produced by the type I NKT cells 
upon stimulation by CD1d–-GalCer (Kawano et al., 1997). 
Accordingly, the phenotypic heterogeneity of MAIT cells 
converges to functional homogeneity toward the potent 
MAIT cell Ag rRL-6-CH2OH. Our findings describe a 
highly specific tetrameric reagent to enable the tracking of 
MAIT cells ex vivo, while simultaneously providing funda-
mental insight into MAIT cell biology and MAIT TCR di-
versity. This reagent will greatly enhance studies of MAIT 
cells in disease as it will enable investigation of these cells in 
mice, and it will overcome concerns about limitations of sur-
rogate phenotypes in humans. Collectively, these advances 
should see the development and use of MAIT cell reagents 
and therapeutics in the clinic.
MATERIALS AND METHODS
Generation of genes encoding mutant MR1-K43A. Mutation of the 
genes encoding soluble human and mouse MR1 at position K43A was gen-
erated by the QuikChange Site-Directed Mutagenesis method (Agilent 
Technologies). A codon-encoding cysteine was next placed at the 3 end the 
human and mouse MR1-K43A genes. Genes encoding the C-terminal cys-
teine–tagged human and mouse MR1-K43A heavy chains and human and 
mouse 2m were expressed separately in BL21 Escherichia coli, and inclusion 
body protein was prepared and solubilized in 8 M urea, 20 mM Tris-HCl, 
pH 8.0, 0.5 mM Na-EDTA, and 1 mM DTT as previously described 
(Kjer-Nielsen et al., 2012). MR1 and 2m were refolded in a buffer contain-
ing either no urea (human MR1) or containing 5 M urea (mouse MR1), 
100 mM Tris, pH 8.0, 2 mM Na-EDTA, 400 mM l-arginine–HCl, 0.5 mM 
oxidized glutathione, 5 mM reduced glutathione, PMSF, and pepstatin A and 
dialyzed in 10 mM Tris before FPLC purification by sequential DEAE anion 
exchange, gel filtration, and Mono-Q anion exchange chromatography as 
described previously (Kjer-Nielsen et al., 2012).
Generation of human and mouse MR1-K43A tetramers. Purified 
C-terminal cysteine–tagged MR1-K43A was “loaded” with rRL-6-CH2OH 
by incubating with a 100 molar excess of rRL-6-CH2OH for 4 h at room 
temperature in the dark. rRL-6-CH2OH–loaded cysteine-tagged MR1-
K43A was then reduced with 5 mM DTT for 20 min before buffer exchange 
into PBS using a PD-10 column (GE Healthcare). The cysteine-tagged 
MR1-K43A was biotinylated with Maleimide-PEG2 biotin (Thermo Fisher 
MAIT cells has also been previously observed (Martin et al., 
2009; Walker et al., 2012) and suggests that some MAIT cells 
may coexpress CD8 heterodimer along with CD8 ho-
modimer. CD8 binds predominantly to the 3 domain of 
MHC-I, and a comparison of the MHC-I–CD8 footprint 
reveals that the equivalent residues and structural features are 
mostly conserved/conservatively substituted between HLA-I 
and MR1 (Kjer-Nielsen et al., 2012). This suggests that MR1 
may have the ability to bind to CD8, and accordingly may 
play a role in augmenting the MAIT cell immune response 
(Gao et al., 1997).
The MAIT cell repertoires are characterized in humans 
and mice by varied TCR -chain usage, with particular 
-chains being predominantly used by both humans and mice. 
We show that the MR1-Ag tetramer binds equally well to 
human MAIT TCRs expressing the TRBV6-1,TRBV 6-4, 
and TRBV20 genes; and mouse MAIT TCRs using V6, 
V8, and other V-chains are capable of binding to MR1-Ag 
tetramer. In agreement with previous studies (Tilloy 
et al., 1999; Walker et al., 2012), TCR sequence analysis from 
human MR1-Ag tetramer–sorted PBMCs shows that as 
well as the frequently used TRBV6 and TRBV20 TCR 
-chains, within the MAIT cell repertoire there is diversifica-
tion through the (less frequent) usage of TRBV28, TRBV25, 
TRBV24, TRBV19, TRBV15, TRBV11-2, TRBV6-5, 
TRBV4-3, and TRBV4-2 -chains. Given that the TCR- 
repertoire is far more diverse in cord blood compared with 
adult blood (Walker et al., 2012), this suggests that TCR 
-chain usage is less of a factor in MAIT TCR develop-
ment but perhaps reflects peripheral expansion of MAIT 
cells in response to microbial challenge. However, it is 
equally clear that human MAIT cells expressing TCR 
-chains other than TRBV6-4 and TRBV20 can be identified 
by the MR1-Ag tetramer. The less stringent requirement 
for particular TCR -chains is consistent with recent MAIT 
TCR structural and mutagenesis data (Reantragoon et al., 
2012; Patel et al., 2013; Young et al., 2013). Alternatively, 
varied MAIT TCR -chain usage may modulate the affinity 
threshold to which MAIT cells respond to MR1-restricted 
Ags, in a manner analogous to that observed in type I NKT 
cells (Mallevaey et al., 2009; Pellicci et al., 2009; Patel et al., 
2011; Rossjohn et al., 2012). Indeed, although the majority 
of MAIT cells were MR1-Ag tetramerhi, a smaller popula-
tion was tetramerintermediate, suggesting that the MAIT TCR 
repertoire can impact avidity toward MR1-Ag. However, 
we did not observe a difference in TCR repertoire between 
MR1-Ag tetramerhi and tetramerintermediate cells (not de-
picted). Surprisingly, in addition to the varied MAIT TCR 
-chain repertoire, we show that the human MAIT TCR 
-chain repertoire can also be heterogeneous. Namely, al-
though the TRAV1-2 gene usage appears to be fixed, the 
TRAJ33 gene can be replaced by TRAJ20 and TRAJ12 
gene segments, which in some individuals appear to repre-
sent a considerable subset of MAIT cells. Although these al-
ternate MAIT TCR -chains display similar functionality 
in comparison with the TRAV1-2–TRAJ33+ MAIT TCRs, 
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culture supernatant was incubated with 10 µl of detection bead mix at 
room temperature for 1 h before addition of 10 µl of detection antibody 
mix and incubated for a further 1 h. Beads were then washed twice before 
data acquisition.
Tetramer-depleted intracellular cytokine staining assay. Human PBMCs 
were stained with rRL-6-CH2OH–loaded human MR1 tetramer–PE at 
20 µg/ml for 40 min at room temperature and bulk sorted for the tetramer-
negative population (tetramer depleted). Undepleted control cells were PBMCs 
not stained with tetramer, but otherwise similarly bulk sorted for lympho-
cytes (using SSC versus FSC gates for both tetramer-depleted and unde-
pleted cells). 2 × 105 of undepleted and tetramer-depleted cells were cultured 
with 2 × 105 C1R.MR1 cells (C1R cells transduced with and expressing 
high levels of human MR1) in the presence of 0.15 or 0.075 µM rRL-6-
CH2OH or 4 or 8 µl S. typhimurium culture supernatant. Additionally, unde-
pleted and tetramer-depleted cells were cultured without C1R.MR1 cells, in 
the absence or presence of either anti-CD3/anti-CD28 mAbs or 10 ng/ml 
PMA/1 µg/ml ionomycin. After overnight culture, cells were surface stained 
with CD3-Pe-Cy7 (eBioscience), CD4-APC-Cy7 (BioLegend), CD8-
PerCP (BD), and CD161-APC (Miltenyi Biotec) and TRAV1-2–FITC (D5; 
Kjer-Nielsen et al., 2012) mAbs for 30 min at 4°C in the dark and then fixed 
with 1% paraformaldehyde (ProSciTech), after which intracellular cytokine 
staining was performed with IFN-–Pacific blue (BioLegend) and gran-
zyme-B–Alexa Fluor 700 (BD) in 0.3% Saponin (Sigma-Aldrich) for 40 min 
at 4°C in the dark.
Activation assay of human MAIT TCR SKW3 cell lines. 105 human 
MAIT TCR SKW3 cells were cultured with 105 C1R cells in the presence 
of 0.152 or 1.52 µM rRL-6-CH2OH, 0.5 or 5 µl S. typhimurium supernatant, 
or S. typhimurium (multiplicity of 10 or 100) in a total volume of 200 µl. 
For the MR1 blocking assay, anti-MR1 mAb (26.5; Huang et al., 2005) or 
isotype control mAb (W6/32; Maziarz et al., 1986) was added to C1R cells 
(20 µg/ml final concentration) for 1 h before culturing with SKW3 cells. 
After overnight culture, cells were stained with CD3-PE (BD) and CD69-
APC (BD) for 30 min at 4°C, before analysis of CD69 surface expression by 
flow cytometry.
Data acquisition on flow cytometers. Data were acquired on FACSCanto 
II, LSR II, and LSRFortessa flow cytometers (BD). Data were analyzed using 
FlowJo analysis software (Tree Star).
Mice. MR1/, V19iTg-C/MR1+/+, and V19iTg-C/MR1/ 
mice (all on C57BL/6 genetic background) were a gift from S. Gilfillan 
(Washington University in St. Louis School of Medicine, St. Louis, MO) to 
T.H. Hansen and Z. Chen. The V19iTg mice were crossed with TCR/ 
(C/) mice to eliminate expression of endogenous TCR chains and then 
to MR1/ mice (V19iTg-C/MR1/; Kawachi et al., 2006). There-
fore, V19iTg-C/MR1+/+ and V19iTg-C/MR1/ mice exclu-
sively express a V19i transgene that is the canonical TCR V of mouse 
MAIT cells. As previously reported, MAIT cells isolated from these Tg mice 
use endogenous TCR V chains and have surface marker characteristics of 
polyclonal MAIT cells (Kawachi et al., 2006). Mice were bred and main-
tained under specific pathogen–free conditions, and protocols used were 
approved by the Animal Studies Committee of Washington University in 
St. Louis and the University of Melbourne.
Isolation of mouse splenic cells. Spleen cells from naive V19iTg-C/ 
MR1+/+ mice, V19iTg-C/MR1/, C57BL/6-MR1/, and wild-
type C57BL/6 mice were aseptically removed and used as the source for 
T cell isolation. A single-cell suspension was prepared, and red blood cells 
were lysed with ammonium chloride buffer. Cells were washed, counted, and 
subjected to magnetic labeling and separation according to the instructions 
of the pan-T cell isolation kit II, negative selection (Miltenyi Biotec).
MR1–rRL-6-CH2OH tetramer staining of mouse splenic T cells. 
Approximately 106 purified T cells were washed with cold FACS staining 
Scientific) with a 30:1 molar ratio of biotin/protein at 4°C for 16 h in the 
dark. Biotinylated MR1 was subjected to S200 10/300 GL (GE Healthcare) 
chromatography to remove excess biotin. Biotinylated, rRL-6-CH2OH–
loaded MR1-K43A monomers were tetramerized with streptavidin conju-
gated to PE (SA-PE; BD) or APC (SA-APC; Invitrogen).
Isolation of PBMCs. Whole blood from healthy donors was collected 
(authorized by the Australian Red Blood Cross Service Material Supply 
Agreement with the University of Melbourne), and PBMCs were separated 
using Ficoll-Paque Premium (GE Healthcare). PBMCs were harvested 
and resuspended in fresh RPMI medium. Cells were then washed twice 
before resuspension in 10% DMSO in FCS. Before use, PBMCS were stored 
in liquid nitrogen.
MR1–rRL-6-CH2OH tetramer staining of human MAIT SKW3 cell 
lines, human PBMCs, and human IELs. Approximately 2 × 105 of 
MAIT SKW3 cell lines, or human IELs, or 106 human PBMCs were stained 
with the empty or rRL-6-CH2OH–loaded versions of human MR1-K43A 
tetramer at 20 µg/ml for 40 min at room temperature in the dark. MAIT 
SKW3 cell lines were then stained with CD3-PE, and human PBMCs were 
stained with CD3-Pe-Cy7 (eBioscience), CD4-APC-Cy7 (BioLegend), 
CD8-PerCP (BD), and CD161-APC (Miltenyi Biotec) or, alternatively, 
CD3–Alexa Fluor 700 (EBioscience), CD8-PE (BD), or CD161-PeCy7 
(BioLegend) for 30 min at 4°C. IELs were stained with CD3-Pe-Cy7 (eBio-
science), CD4-APC-Cy7 (BioLegend), CD161-APC (Miltenyi Biotec), and 
anti–TRAV1-2 D5-FITC or isotype control (anti–pre-TCR) 8A5-FITC. Cells 
were then washed once with 2 ml FACS wash (2% FBS in PBS) and resus-
pended in 90 µl FACS fix (2.1% glucose and 1% paraformaldehyde in PBS).
Intestinal lymphocyte cell preparation and tissue immunohistochem-
istry. Human jejunum mucosa was obtained from a patient undergoing a 
Whipple’s procedure and processed by the Australian Phenomics Histopa-
thology Facility at the University of Melbourne. IELs and lamina propria 
lymphocytes were prepared essentially as described previously (Van Damme 
et al., 2001). In brief, mucosa was dissected away from underlying cell layers 
and washed briefly in PBS to remove blood and debris. Mucosal tissue was 
then incubated in PBS for 1 h at 37° with gentle agitation to allow dispersion 
of IELs. Tissue was allowed to settle and cells were then filtered (100 µM). 
The lamina propria lymphocyte cell fraction was obtained through further 
processing of tissue by manual cutting to 1–5 mm, followed by digestion with 
50 U/ml Collagenase IV (Worthington Biochemical Corporation) for 2 h at 
37°C with gentle agitation. Tissue was allowed to settle and cells were then 
filtered (100 µM) before analysis. For immunohistochemistry experiments, 
jejunal tissue was collected into cold PBS in the operating theater and then 
fixed in cold 4% formaldehyde. Fixative was washed out with PBS, and cryo-
sections were made and processed for immunohistochemistry using the anti–
TRAV1-2 mAb D5 (Kjer-Nielsen et al., 2012). mAb reactivity was detected 
using a peroxidase-coupled second antibody, and standard immunohisto-
chemistry was conducted at the Australian Phenomics Histopathology and 
Organ Pathology service at the Department of Anatomy and Neuroscience 
at the University of Melbourne. This work was conducted under Ethics 
Approval H2011/04231.
CBA with human PBMCs. Human PBMCs were stained with the rRL-6- 
CH2OH–loaded human MR1 tetramer–PE at 20 µg/ml for 40 min at room 
temperature before staining with CD3-PeCy7 (eBioscience), CD4–Pacific 
blue (eBioscience), -TCR-FITC (BD), CD161-APC (Miltenyi Biotec), 
and CD8-APCH7 (BD) for 30 min at 4°C in the dark. CD3+CD161+tetramer+ 
cells were sorted. Approximately 5,000 cells were incubated with anti-CD3/
anti-CD28 beads (4 × 105 beads/well), 10 ng/ml PMA/1 µg/ml ionomycin, 
or with 10,000 C1R.MR1 cells in the presence of 1.52 µM rRL-6-CH2OH 
or 8 µl S. typhimurium supernatant in a final volume of 80 µl. At 24 and 60 h, 
20 µl of supernatant was collected and replaced with fresh media (RPMI-
1640 [Gibco] in supplement and 10% FCS). Supernatants were analyzed 
using CBA human flex sets for IFN-, TNF, and IL-2 (BD). In brief, 10 µl of 
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96°C for 10 s, 50°C for 5 s, and 60°C for 4 min. The DyeEx 96 kit (QIAGEN) 
was used to remove dye terminators, according to the manufacturer’s proto-
col. Samples were sent to the Sequencing and Genotyping Facility, Depart-
ment of Pathology, the University of Melbourne for electrophoresis and 
sequencing. Sequences were determined using IMGT/V-QUEST software.
Crystallization, structure determination, and refinement. Ternary 
MR1-K43A–RL-6-Me-7-OH plus MAIT TCR complex (6–10 mg/ml) 
crystallized at 294 K in 0.2 M sodium acetate, 0.1 M Bis-Tris-Propane, 
pH 6.5, and 20% PEG 3350. Crystals were flash frozen before data collection 
using 10% glycerol as the cryoprotectant. The data were collected at 100 K 
on the 031D1 beamline at the Australian Synchrotron, Melbourne. The crys-
tals diffracted to 2.4 Å and belong to the space group C2, with two molecules 
within the asymmetric unit. The data were processed using Mosflm version 
7.0.5 (Leslie, 2006) and scaled using SCALA from the CCP4 Suite (CCP4, 
1994). The data for ternary MR1-K43A–RL-6-Me-7-OH plus MAIT TCR 
complex was solved using MR1–RL-6-Me-7-OH plus MAIT TCR com-
plex (Protein Data Bank accession no. 4L4V) without the ligand (Patel et al., 
2013). To prevent model bias, the Rfree set of the MAIT TCR-MR1–6-FP 
(Protein Data Bank accession no. 4L4T) data was used in the experimental 
intensities scaling using SCALA as well as the implementation of the simu-
lated annealing protocol in Phenix (Zwart et al., 2008). Refinement was per-
formed using BUSTER 2.10. Model building was performed using COOT 
(Crystallographic Object-Oriented Toolkit). The quality of structure was val-
idated at the Research Collaboratory for Structural Bioinformatics Protein 
Data Bank Data Validation and Deposition Services. All molecular graphics 
representations were created using PyMOL. The coordinates were deposited 
in the Protein Data Bank under the accession number 4LCW.
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buffer (1× PBS with 2% FBS), pelleted, and stained with 20 µg/ml PE- 
conjugated negative control mouse MR1-K43A tetramer (empty) or PE-
conjugated rRL-6-CH2OH–loaded mouse MR1 tetramer in 10 µl (final 
volume) FACS staining buffer (in FACS tubes; BD) for 45 min at room 
temperature in the dark. Immediately thereafter (no washing step), surface 
Ags, including CD3, CD4, CD8, V6 TCR, and V8.1/8.2 TCR were 
stained for 20 min on ice with anti–mouse CD3–Pacific blue (BD), anti–
mouse CD4-PerCP (BioLegend), anti–mouse CD8-APC-H7 (BD), anti–
mouse V6 TCR-FITC (BD), and anti–mouse V8.1/8.2 TCR-FITC (BD), 
respectively. Cells were then washed once with 2 ml FACS staining buffer 
and resuspended in 200 µl FACS staining buffer.
CBA with mouse splenic T cells. Splenocytes from a V19iTg-C/ 
MR1+/+ mouse were stained with 20 µg/ml PE-conjugated rRL-6-CH2OH–
loaded mouse MR1-K43A tetramer in 10 µl (final volume) FACS staining 
buffer before staining with anti–mouse CD3-APC, anti–mouse V6 TCR-
FITC (BD), and anti–mouse V8.1/8.2 TCR-FITC (BD). V6/V8.1/
8.2CD3+tetramer+, V6+/V8.1/8.2+CD3+tetramer+, or control CD3+ 
tetramer cells were sorted, and 20,000 cells were incubated with anti-
CD3/anti-CD28 mAbs or 10 ng/ml PMA/1 µg/ml ionomycin or with 
20,000 M12.C3.murineMR1 cells (Griffith et al., 1988; expressing high lev-
els of transduced mouse MR1) in the absence or presence of 15.2 µM rRL-
6-CH2OH in a final volume of 200 µl. At 24 h, 5 µl of supernatant was 
collected and analyzed using CBA mouse flex sets for IFN- and TNF (BD). 
In brief, 5 µl of culture supernatant (diluted to 10 µl) was incubated with 
10 µl of detection bead mix at room temperature for 1 h before addition of 
10 µl of detection antibody mix and incubated for a further 1 h. Beads were 
then washed twice before data acquisition.
Activation assay of BW5147-mouse MAIT TCR cell lines. Spleno-
cytes from a V19iTg-C/MR1+/+ mouse were stained with CD3- and 
V6/V8-reactive mAbs, and rRL-6-CH2OH–loaded MR1-K43A tetramer 
and CD3+MR1 tetramer+V6/V8 or CD3+MR1 tetramer+V6/V8+ 
cells were then sorted by flow cytometry before fusion with the BW5147 cell 
line as previously described (de Kauwe et al., 2009). BW5147-MAIT hybrid-
omas, either nonreactive with rRL-6-CH2OH–loaded mouse MR1-K43A 
tetramer or either MR1-Ag tetramer+V6/V8 or MR1-Ag tetramer+V6/
V8+, were then coincubated with M12.C3.MR1 cells in the absence or 
presence of 15.2 µM rRL-6-CH2OH. Alternatively BW5147-MAIT hybrid-
omas were incubated alone or in the presence of plate-bound CD3- and 
CD28-reactive mAbs (BD). IL-2 release by BW5147-MAIT hybridomas was 
assayed by indirect ELISA with the conversion of o-phenylenediamine dihydro-
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